Eslicarbazepine acetate in the management of refractory bipolar disorder

Kamal Nath, Arnab Bhattacharya, Samir Kumar Praharaj

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect.

Original languageEnglish
Number of pages1
JournalClinical Neuropharmacology
Volume35
Issue number6
DOIs
Publication statusPublished - 01-11-2012

Fingerprint

Antimanic Agents
Carbamazepine
Bipolar Disorder
Anticonvulsants
eslicarbazepine acetate
eslicarbazepine
oxcarbazepine

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

@article{c6d48262c3ac49cab373caa3544f6931,
title = "Eslicarbazepine acetate in the management of refractory bipolar disorder",
abstract = "Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect.",
author = "Kamal Nath and Arnab Bhattacharya and Praharaj, {Samir Kumar}",
year = "2012",
month = "11",
day = "1",
doi = "10.1097/WNF.0b013e318271220b",
language = "English",
volume = "35",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

Eslicarbazepine acetate in the management of refractory bipolar disorder. / Nath, Kamal; Bhattacharya, Arnab; Praharaj, Samir Kumar.

In: Clinical Neuropharmacology, Vol. 35, No. 6, 01.11.2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Eslicarbazepine acetate in the management of refractory bipolar disorder

AU - Nath, Kamal

AU - Bhattacharya, Arnab

AU - Praharaj, Samir Kumar

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect.

AB - Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect.

UR - http://www.scopus.com/inward/record.url?scp=84870015852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870015852&partnerID=8YFLogxK

U2 - 10.1097/WNF.0b013e318271220b

DO - 10.1097/WNF.0b013e318271220b

M3 - Article

C2 - 23151469

AN - SCOPUS:84870015852

VL - 35

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 6

ER -